Key result
AVJA increases biventricular pacing by ~9% vs no ablation or rate control.
Why the study?
Atrial fibrillation commonly causes suboptimal CRT delivery because intrinsic atrioventricular conduction reduces effective biventricular capture.
Does atrioventricular junction ablation improve biventricular pacing and clinical outcomes in CRT recipients with atrial fibrillation?
Meta-Analysis (n=16)
Does atrioventricular junction ablation improve biventricular pacing and clinical outcomes in CRT recipients with atrial fibrillation?
Answers are grounded in this paper and cite their sources.
AVJA significantly improves biventricular pacing in CRT recipients with atrial fibrillation, but contemporary evidence does not show statistically significant improvements in mortality or heart failure hospitalizations.
Atrial fibrillation is a common cause of suboptimal cardiac resynchronization therapy (CRT) delivery because intrinsic atrioventricular conduction reduces effective biventricular capture. We performed an updated systematic review and meta-analysis evaluating atrioventricular junction ablation (AVJA) versus no AVJA or pharmacological rate control in CRT recipients with atrial fibrillation. PubMed, Scopus, and Cochrane Library were searched through February 16, 2026. Sixteen studies were included, comprising 14 observational cohorts and 2 randomized trials. AVJA significantly increased biventricular pacing (mean difference 8.80 percentage points, 95% confidence interval [CI] 5.99-11.61). All-cause mortality (risk ratio [RR] 0.74, 95% CI 0.51-1.10), cardiovascular mortality (RR 0.79, 95% CI 0.49-1.27), and heart failure hospitalization (RR 0.73, 95% CI 0.18-2.97) were directionally favorable but not statistically significant. Remodeling, functional, quality-of-life, and clinical responder outcomes were modest or neutral. Contemporary device-therapy data suggested fewer inappropriate shocks and ventricular arrhythmia-related therapies with AVJA, although reporting heterogeneity precluded formal pooling. AVJA remains a dependable CRT-optimization strategy for selected patients with atrial fibrillation, especially when biventricular pacing is inadequate, but contemporary evidence supports a more measured interpretation of downstream clinical benefit.
No takes yet. Share an insight, caveat, or question.
Abomohsen et al. (2026) conducted a meta-analysis in Atrial fibrillation in cardiac resynchronization therapy (CRT) recipients (n=16). Atrioventricular junction ablation (AVJA) vs. No AVJA or pharmacological rate control was evaluated on Biventricular pacing (MD 8.80, 95% CI 5.99-11.61). Atrioventricular junction ablation increased biventricular pacing compared to no ablation or rate control.
Synapse has enriched 10 related papers. Consider them for comparative context: